• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
IT·Science
Internet

LG Corp. to Build AI-Based New Drug Development Platform for Dong-A Socio Group

LG CNS (#LGCNES) announced on the 12th that it has completed the construction of an AI-based new drug development platform for the Dong-A Socio Group in collaboration with DAI, the group’s IT subsidia…
  • 2026-08-12 10:00:04
  • Shin Yeong-bin
Telecommunications & Broadcasting

KTCorporation Reports 648.3 Billion Won in Second-Quarter Operating Profit… Earnings Improve Driven by 'AX and Cloud'

KTCorporation(030200)has shown a marked improvement in earnings, driven by balanced growth in its core business and new ventures, despite the negative base effect from large one-time gains and externa…
  • 2026-08-12 09:54:33
  • Yun Junghoon
Telecommunications & Broadcasting

[Breaking News] KTCorporation Reports 2nd-Quarter Operating Profit of 648.3 Billion Won… Down 36.1% Year-Over-Year

KTCorporation(030200)reported that its consolidated operating profit for the second quarter of this year fell by more than 30% year-over-year. This is largely attributed to a base effect resulting fro…
  • 2026-08-12 09:46:21
  • Yun Junghoon
Technology

Celltrion Sees Success in Spain and Portugal Tenders… Direct Sales Strategy Pays Off

On the 12th, Celltrion(068270)announced that it is rapidly strengthening its market influence by continuing to secure tender wins and expand prescriptions in Spain and Portugal.First, “Omriclo” (activ…
  • 2026-08-12 09:43:02
  • Minji Son
Internet

Following Samsung SDS, LG Uplus Also Targets the AWS Public Sector Market… Competition in the “Public Cloud” Sector

LG Uplus(032640)is set to target the public cloud market with Amazon Web Services (AWS) at the forefront. Following Samsung SDS, major domestic IT and telecommunications companies are entering the mar…
  • 2026-08-12 09:41:28
  • Kim Hyun-ah
Technology

FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Hopes for Follow-On Licensing [K-Bio Pulse]

On August 10, South Korean pharmaceutical and biotech stocks rose across the board as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed following a 5-for-1 reverse stock…
  • 2026-08-12 08:02:04
  • Minji Son
Technology

From Bio Co., Ltd. Hits Daily Limit Up as Trading Resumes… curacle co., ltd. Also Surges on Expectations of ‘Follow-up Technology Transfer’ [Bio Spotlight]

On the 10th, domestic pharmaceutical and biotech stocks showed an overall upward trend, buoyed by a rebound in the KOSDAQ index. From Bio Co., Ltd.(377220), which resumed trading that day after comple…
  • 2026-08-12 08:02:02
  • Minji Son
Telecommunications & Broadcasting

PIERS·Yeoncheon Paleolithic Expo… This Week’s Must-See Events

2026 Seoul Summer Beach Water Wave Zone (Photo: Seoul Tourism Foundation) ◇Seoul Summer Beach Attracts 3.22 Million Visitors Over 21 DaysA total of 3.22 million people visited the urban summer fest…
  • 2026-08-12 06:00:04
  • LEE SEON-WOO
Gaming

PearlAbyss Corp. Reports Operating Profit of 67.6 Billion Won… Up 7,411% Year-Over-Year, a “Huge Jump”

PearlAbyss Corp.(263750)reported a 7,411% year-over-year increase in operating profit for the second quarter of 2026, driven by the success of *Red Desert*.PearlAbyss Corp. announced that for the seco…
  • 2026-08-11 18:20:23
  • An Yu-ri
Technology

Lunit Inc. Reports First-Half Revenue of 45.8 Billion Won, a “Record High”… Operating Loss Narrowed by 31%

(Source: Lunit Inc.) Medical artificial intelligence (AI) company Lunit Inc.(328130)posted its highest-ever first-half revenue, driven by growth in its overseas cancer screening business and its A…
  • 2026-08-11 18:02:02
  • Minji Son
prev 11 12 13 14 15 16 17 18 19 20 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English